Loading
Latest filing published 20 Feb 2026 for Tivic Health Systems, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Michael K. Handley span 2 companies, the busiest being Cytocom, Inc. and Valion Bio, Inc. In total, 2 filings cover trades dated from 27 July 2021 to 18 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 20 February 2026: an option exercise, in Valion Bio, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations